Tech Company Financing Transactions
Biocept Funding Round
Biocept, based in San Diego, secured $1 million from Needham Capital Partners.
Transaction Overview
Company Name
Announced On
12/3/2004
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Series E
Investors
Proceeds Purpose
The company intends to develop and launch products for the pharmaceutical, biotechnology, academic, and medical sectors.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
5810 Nancy Ridge Dr. 150
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Biocept, Inc. is a San Diego, California-based molecular oncology diagnostics company that specializes in circulating tumor cell (CTC) and biomarker analysis
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Nall
Chief Financial Officer
Timothy Kennedy
Chief Medical Officer
Veena Singh
Chief Scientific Officer
Lyle Arnold
Vice President
Amy McNeal
VP - Bus. Development
David Moskowitz
VP - General Counsel
Michael Brown
VP - Operations
Michael Terry
VP - Sales
Cory Cairns
Browse more venture capital transactions:
Prev: 12/2/2004: Radianse venture capital transaction
Next: 12/4/2004: Catalyst Biosciences venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs